Welcome to our dedicated page for National Health SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The National HealthCare Corporation (NHC) SEC filings page provides access to the company’s regulatory disclosures as a NYSE American issuer. NHC’s common stock, with a par value of $0.01 per share, is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades under the symbol NHC. Through its affiliates, the company operates skilled nursing facilities, assisted living and independent living communities, behavioral health hospitals, homecare agencies, and hospice agencies, along with Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and management and accounting services to third party post-acute operators.
In its Form 8-K current reports, NHC discloses material events such as quarterly and annual earnings releases, dividend declarations, and significant lease and governance matters. For example, the company files 8-Ks to furnish earnings press releases for periods ended March 31, June 30, September 30, and December 31, and to announce quarterly common dividends. These filings often reference non-GAAP financial measures and include or incorporate reconciliations to GAAP results.
NHC’s 8-K filings also describe corporate governance and executive changes, including the appointment of new directors, committee assignments, and planned retirements of senior officers, as well as role changes for executives. Additional 8-Ks address lease arrangements, such as disclosures about a master lease with National Health Investors, Inc., letters alleging non-monetary non-compliance, cure periods, renewal options, and the potential for a material adverse impact on NHC’s financial position and results of operations if certain lease rights were lost.
On this page, users can review NHC’s SEC reports as they are made available through EDGAR and use AI-powered summaries to understand the key points in lengthy filings. These tools can help clarify topics such as segment reporting for inpatient services and home care hospice services, dividend practices, lease terms and disputes, and board and executive leadership changes, without replacing the full text of the official documents.
National HealthCare Corporation is asking shareholders to vote at its 2026 annual meeting on May 7, 2026 in Murfreesboro, Tennessee. Items include re‑electing directors Emil E. Hassan, Lisa Piercey, M.D., and William A. “Andrew” Adams and an advisory vote on executive pay.
For 2025, pre‑tax earnings excluding unrealized securities gains were $137,497,000, creating an executive bonus pool of $6,874,841, split 80% cash and 20% restricted stock. CEO Stephen F. Flatt’s 2025 pay totaled $2,685,370, including a $577,000 salary and $1,280,000 bonus. The company highlights board independence, refreshed membership, sustainability efforts, and updated insider trading, clawback, and cybersecurity oversight policies.
National HealthCare Corp Schedule 13G/A: The Vanguard Group amended its beneficial ownership filing following an internal realignment. The amendment states amount beneficially owned: 0 shares and percent of class: 0%. The filing explains certain subsidiaries/divisions now report separately in reliance on SEC Release No. 34-39538 (January 12, 1998), and Vanguard no longer is deemed to beneficially own the securities held by those units. The filing is signed by a Vanguard officer on 03/27/2026.
NATIONAL HEALTHCARE CORP senior vice president Vicki L. Dodson exercised stock options and increased her direct shareholdings. She exercised options for 3,734 shares of common stock at an exercise price of $53.94 per share. To cover the exercise price and related tax obligations, the company withheld 2,034 shares valued at $164.96 per share, a non-market tax-withholding disposition rather than an open-market sale. After these transactions, she directly owns 14,412.5455 shares of common stock. She also continues to hold stock options over 8,000 shares at $94.10 per share expiring on March 5, 2029, 9,000 shares at $90.62 per share expiring on February 24, 2030, and 14,000 shares at $157.13 per share expiring on February 23, 2031.
National Healthcare Corp CEO Stephen Fowler Flatt exercised stock options to acquire 1,853 shares of common stock at an exercise price of $53.94 per share. These options were originally granted on March 8, 2023 under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).
Following the transaction, Flatt directly holds 65,505 shares of common stock. He also retains stock options covering 10,000 shares at $94.10, 13,000 shares at $90.62, and 20,000 shares at $157.13, with expiration dates between 2029 and 2031.
National HealthCare Corp SVP and CFO Brian F. Kidd exercised stock options for 1,853 shares of common stock at an exercise price of $53.94 per share. The options were originally granted under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).
Following the transaction, Kidd directly holds 29,130 shares of common stock. He also continues to hold options over 8,000 shares at an exercise price of $94.10, 9,500 shares at $90.62, and 14,000 shares at $157.13, with expirations between 2029 and 2031.
National Healthcare Corp Schedule 13G/A amendment reports Morgan Stanley entities as passive holders of Common Stock (CUSIP 635906100). The filing lists 1,102,537 shares beneficially owned by Morgan Stanley reporting units, representing 7.1% of the class, and 1,038,787 shares beneficially owned by Morgan Stanley Institutional Investment Advisors LLC, representing 6.7%.
The filing provides corporate addresses for the filers, cites Release No. 34-39538 for reporting-unit aggregation, and is signed by authorized signatories with dates of 03/12/2026. Exhibit references include a joint filing agreement and Item 7 subsidiary information.
National Healthcare Corp director James Paul Abernathy exercised stock options and increased his direct shareholdings. He exercised options covering 3,140 shares of common stock at an exercise price of $55.75 per share, receiving 3,140 common shares. Following the transaction, he directly owns 43,302 common shares.
The exercised options were part of a 2023 grant under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d). Abernathy still holds two additional option grants, each linked to 7,500 underlying common shares, with exercise prices of $96.03 and $94.66 per share and expirations in 2029 and 2030.
NATIONAL HEALTHCARE CORP Sr. VP of Patient Services Vicki L. Dodson reported option-related transactions in company stock. On March 4, 2026, she exercised 4,500 stock options granted under the 2020 Omnibus Equity Incentive Plan, receiving 4,500 common shares at an exercise price of $0.00 per share and a corresponding entry at $90.62 per share for the acquired stock.
In a separate transaction coded "F," 3,159 shares of common stock were withheld by the company to cover the exercise price and tax-withholding obligations, rather than sold on the open market. Following these transactions, she beneficially owns 12,712.5455 shares of NATIONAL HEALTHCARE CORP common stock directly, and continues to hold multiple option awards with remaining exercisable balances.
National HealthCare Corp senior VP & CIO Ben Anderson Sr reported option exercises and related share withholdings. On March 4, 2026 he exercised multiple “Option to Purchase Common Stock” grants under the 2020 Omnibus Equity Incentive Plan into common shares. The company then withheld a portion of common stock to cover the exercise price and tax obligations, as noted in the footnotes. Following these transactions, he beneficially owned a total of 19,550.0547 shares of National HealthCare Corp common stock.
NATIONAL HEALTHCARE CORP Senior VP & General Counsel Josh A. McCreary reported option-related transactions in company stock. On March 4, 2026, he exercised options for 4,500 shares of common stock at an exercise price of $90.62 per share.
To cover the exercise price and related tax withholding obligations, 3,202 shares of common stock were withheld by the company, classified as a tax-withholding disposition rather than an open-market sale. Following these transactions, McCreary directly beneficially owned 12,698 shares of NATIONAL HEALTHCARE CORP common stock.